This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignees: Plasmidfactory Gmbh + Co Kg, Qiagen Gmbh. Active years: 2003-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2016
Title: Martin Schleef: Innovator in Viral Vector Technology
Introduction
Martin Schleef is a notable inventor based in Bielefeld, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of viral vectors. With a total of 2 patents, his work has advanced the methods used in genetic engineering and cell transformation.
Latest Patents
Schleef's latest patents include innovative technologies that enhance the production and application of viral vectors. One of his key inventions is a minicircle transfer vector designed for producing viral vectors. This invention includes a transfer sequence and specific packing signals that facilitate the packaging of the transfer sequence into viral vector particles. Additionally, he has developed methods for producing viral vectors using these minicircles, which also encompass kits useful for performing the described methods. Another significant patent focuses on the isolation of ccc plasmid DNA, which involves culturing bacterial transformants in a bioreactor under specific conditions to optimize biomass production.
Career Highlights
Throughout his career, Martin Schleef has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Qiagen GmbH and Plasmidfactory GmbH & Co. KG. His experience in these organizations has contributed to his expertise in the field and the successful development of his patented technologies.
Collaborations
Some of his notable coworkers include Torsten Schmidt and Karl Friehs. Their collaboration has likely played a role in advancing the research and development efforts in which Schleef has been involved.
Conclusion
Martin Schleef's contributions to viral vector technology and genetic engineering are significant. His innovative patents and career achievements reflect his dedication to advancing biotechnology. His work continues to influence the field and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
